Company Profile
JURA Bio, Inc.
Company Overview
JURA Bio, Inc. makes engineered cell-based therapeutics that capitalize on one of the body's most important immune synapses to directly target the immune cells responsible for autoimmune disorders. We aim to restore a healthy immune system to patients suffering from primary progressive multiple sclerosis, myasthenia gravis, and a host of other immune-mediated disorders.
Company History
JURA Bio, Inc. was founded in 2017 by genetic engineering pioneer Dr. Julie Norville, computational biophysicist Dr. Elizabeth Wood, and Harvard Professor George Church.
Our Scientific Advisory Board members include:
David Hafler, MD; Kevan Herold, MD; Jay Fishman, MD; Melina Fan, PhD; Everett Meyer, MD, PhD; Debora Marks, PhD; Hollie Schmidt